PLEGRIDY 63 micrograms + 94 micrograms, solution for injection in a pre-filled syringe syringe, 0.5 ml
Active ingredients: Peginterferon beta-1a
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.5 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PLEGRIDY 63 microgrammes + 94 microgrammes, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable et solution injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,5 ml - 1 seringue(s) préremplie(s) en verre de 0,5 ml
- Marketing authorisation holder
- BIOGEN NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Oct 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69002701CIP72794903CIP133400927949036Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PÉGINTERFÉRON BÊTA-1Asolution de 63 microgrammes | 63 microgrammes · une seringue préremplie | SA |
| PÉGINTERFÉRON BÊTA-1Asolution de 94 microgrammes | 94 microgrammes · une seringue préremplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.